Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review
Birth Defects Research · 2026
DOI: 10.1002/bdr2.70109 ↗Kurz gefasst
Fallbericht in der Zeitschrift Birth Defects Research, 2026. Verfasst von Liangliang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Kangbao Biological Products Co. Ltd., Changzhi, Shanxi Province, China. Hauptthemen laut MEDLINE: Afibrinogenemia, Fibrinogen, Mutation. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Shanxi Provincial Key Research and Development Project.
Abstract (Originalsprache)
Background
Congenital afibrinogenemia is an extremely rare autosomal recessive bleeding disorder with an estimated incidence of one in one million, caused by mutations in the fibrinogen‐encoding genes.
Methods
We report a genetically confirmed case of FGA‐related congenital afibrinogenemia in a 9‐year‐old female child. Comprehensive coagulation analysis revealed undetectable fibrinogen activity (FIB:C, < 0.2 g/L) as measured by the Clauss assay, along with significantly prolonged prothrombin time, activated partial thromboplastin time, and thrombin time.
Results
Next‐generation sequencing targeting coagulation‐related genes identified compound heterozygous mutations in FGA (NM_000508): a paternal nonsense mutation c.502C>T (p.Arg168Ter) in Exon 4 and a maternal frameshift mutation c.668delT (p.Leu223ArgfsX2) in Exon 5. These pathogenic variants were further confirmed by Sanger sequencing in the proband and her parents, which demonstrated that the proband carried the two FGA variants in a compound heterozygous state, with paternal inheritance of c.502C>T and maternal inheritance of c.668delT.
Conclusion
This case expands the genotype–phenotype correlation database for fibrinogen disorders and underscores the necessity of molecular diagnosis for congenital coagulation defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanxi Kangbao Biological Products Co. Ltd., Changzhi, Shanxi Province, China.
- Beijing Hiphar Medical Technology Co. Ltd., Beijing, China.
- Department of Burn Surgery, The Second People's Hospital of Changzhi, Changzhi, Shanxi Province, China.
- Department of Pharmacy, The Second People's Hospital of Changzhi, Changzhi, Shanxi Province, China.
ORCID-Profile: Bacui Yu
Förderung
- Shanxi Provincial Key Research and Development Project
Zitieren
APA
Liu, L., Yuan, D., Zhao, H., & Yu, B. (2026). Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review. Birth Defects Research. https://doi.org/10.1002/bdr2.70109
Vancouver
Liu L, Yuan D, Zhao H, Yu B. Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review. Birth Defects Research. 2026. doi:10.1002/bdr2.70109
BibTeX
@article{Liu2026,
author = {Liu, Liangliang and Yuan, Desheng and Zhao, Huaxing and Yu, Bacui},
title = {Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review},
journal = {Birth Defects Research},
year = {2026},
doi = {10.1002/bdr2.70109}
}
EUVIMED